Philips Healthcare

CHICAGO, November 28, 2011 - - Ingenuity TF PET/MR enables clinicians and researchers to open new frontiers and push the bounds of what's possible in imaging Royal Philips Electronics (NYSE: PHG, AEX: PHI) is announcing 510(k) clearance from the Food and Drug Administration (FDA) for the company's first commercially available whole body positron emission tomography/magnetic resonance (PET/MR) imaging system, the Ingenuity TF PET/MR.